Correction: Non-invasive  in vivo  molecular imaging of intra-articularly transplanted immortalized bone marrow stem cells for osteoarthritis treatment

Bou-Yue Peng; Chi-Sheng Chiou; Navneet Kumar Dubey; Sung-Hsun Yu; Yue-Hua Deng; Feng-Chou Tsai; Han-Sun Chiang; Ying-Hua Shieh; Wei-Hong Chen; Win-Ping Deng

doi:10.18632/oncotarget.25501

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Non-invasive in vivo molecular imaging of intra-articularly transplanted immortalized bone marrow stem cells for osteoarthritis treatment

PDF | How to cite

Oncotarget. 2018; 9:25383-25383. https://doi.org/10.18632/oncotarget.25501

Metrics: PDF 1156 views | ?

Bou-Yue Peng^1,2, Chi-Sheng Chiou^2,3, Navneet Kumar Dubey^4,5, Sung-Hsun Yu^4,6, Yue-Hua Deng^4,7, Feng-Chou Tsai⁸, Han-Sun Chiang⁷, Ying-Hua Shieh^10,11, Wei-Hong Chen⁴ and Win-Ping Deng^2,4,9

¹Oral and Maxillofacial Surgery Section, Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan
²School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan
³Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan
⁴Stem Cell Research Center, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan
⁵Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
⁶Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan
⁷Department of Life Science, Fu Jen Catholic University, Taipei, Taiwan
⁸Department of Stem Cell Research, Cosmetic Clinic Group, Taipei, Taiwan
⁹Graduate Institute of Basic Medicine, Fu Jen Catholic University, Taipei, Taiwan
¹⁰Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
¹¹Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan

Published: May 18, 2018

This article has been corrected: The 2nd affiliation is added to the author given below:

Bou-Yue Peng^1,2

Original article: Oncotarget. 2017; 8:97153-97164. DOI: https://doi.org/10.18632/oncotarget.21315.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25501

Publication Alerts

Corrections:

Correction: Non-invasive in vivo molecular imaging of intra-articularly transplanted immortalized bone marrow stem cells for osteoarthritis treatment